Welcome to our dedicated page for Concentrix SEC filings (Ticker: CNXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Concentrix's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Concentrix's regulatory disclosures and financial reporting.
Concentrix Corp President and CEO Christopher A. Caldwell, who also serves as a director, reported a disposition of company common stock. On 02/01/2026, he disposed of 5,693 shares at a price of $37.35 per share, in a transaction coded "F."
Following this transaction, Caldwell directly beneficially owned 356,382 shares of Concentrix common stock. The filing is made as a single‑person Form 4, reflecting his status as both an officer and director of the company.
Concentrix Corp's Chief Financial Officer reports a small share disposition. CFO Andre S. Valentine filed a Form 4 showing the disposition of 864 shares of Concentrix common stock on February 1, 2026, at a price of $37.35 per share under transaction code "F," typically used for tax withholding on equity awards.
After this transaction, Valentine directly beneficially owns 86,566 shares of Concentrix common stock. The filing reflects routine insider equity administration rather than a large open-market trade.
Concentrix Corp executive Gibson Craig, EVP of Global Sales and Account Management, reported a disposition of common stock in a Form 4 filing. On February 1, 2026, Craig disposed of 799 shares of Concentrix common stock at $37.35 per share. After this transaction, he directly owned 53,599 shares of Concentrix common stock.
Concentrix Corp executive Jane Fogarty, EVP, Legal, reported a disposition of Concentrix common stock. On 02/01/2026, 563 shares were disposed of at a price of $37.35 per share. Following this transaction, she directly beneficially owned 31,030 shares of Concentrix common stock.
Concentrix Corp President and CEO Christopher A. Caldwell reported buying additional company stock in an open-market transaction. On January 29, 2026, he purchased 1,000 shares of Concentrix common stock at a price of $37.07 per share, coded as a purchase transaction.
Following this trade, Caldwell beneficially owned 362,075 shares of Concentrix common stock, held in direct ownership. This filing reflects an increase in his personal equity stake and aligns his financial interests further with those of other shareholders.
Groupe Bruxelles Lambert and its affiliates amended their Schedule 13D on Concentrix Corporation to update ownership percentages. They report beneficial ownership of 8,773,667 shares of common stock, representing about 14.24% of Concentrix’s outstanding shares, based on 61,597,304 shares outstanding as of January 16, 2026.
The change in percentage ownership results solely from a decrease in Concentrix’s total shares outstanding. The filing also notes potential receipt of 442,759 additional earnout shares if specified share-price conditions are met and reiterates investor rights, including board nomination, lock-up, and registration rights under an existing Investor Rights Agreement.
Concentrix Corp President and CEO Christopher A. Caldwell reported routine equity compensation activity involving company common stock. On January 28, 2026, he acquired 2,855 shares of common stock at $0 per share upon the vesting of restricted stock units granted under the 2020 Stock Incentive Plan and tied to performance metrics over a three-year period ending November 30, 2025.
On the same date, 1,210 shares were withheld at a price of $36.32 per share, a transaction coded as "F," typically reflecting shares surrendered to cover tax obligations. After these transactions, Caldwell directly owned 361,075 shares of Concentrix common stock.
Concentrix Corp Chief Financial Officer Valentine Andre S reported stock transactions dated January 28, 2026. The filing shows an acquisition of 436 shares of common stock at $0 per share, tied to restricted stock units that vested under the 2020 Stock Incentive Plan after performance was measured over a three-year period ending November 30, 2025.
The report also shows a disposition of 130 shares of common stock at $36.32 per share on the same date. After these transactions, the executive directly held 87,430 shares of Concentrix common stock.
Concentrix Corp EVP Cormac J. Twomey reported routine equity compensation activity. On January 28, 2026, he acquired 491 shares of common stock at $0 upon vesting of performance-based restricted stock units granted under the 2020 Stock Incentive Plan. On the same date, 231 shares were disposed of at $36.32 per share, reflecting shares withheld to cover taxes. After these transactions, he directly owned 58,434 Concentrix common shares.
Concentrix Corp executive Jane Fogarty reported routine equity compensation activity. On January 28, 2026, she acquired 220 shares of common stock at $0 per share upon vesting of performance-based restricted stock units granted under the 2020 Stock Incentive Plan. On the same date, 79 shares were disposed of at $36.32 per share, typically reflecting shares withheld to cover taxes, leaving her with 31,593 shares of Concentrix common stock held directly.